Kevin Johnson
Algemeen Adviseur bij Tourmaline Bio, Inc.
Vermogen: 925 344 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Kevin Johnson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
| Subsidiary | Pharmaceuticals: Major | 11 | |
9
| Extinct | Pharmaceuticals: Major | 9 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
| Extinct | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Kevin Johnson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Director/Board Member Director/Board Member Private Equity Investor | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member Director/Board Member Chief Investment Officer | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| IMMUNOVANT, INC. | Biotechnology | General Counsel Chief Operating Officer | |
| PDS BIOTECHNOLOGY CORPORATION | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| Licensing Executives Society | Corporate Officer/Principal Corporate Officer/Principal | ||
| ZURA BIO LIMITED | Biotechnology | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| George Washington University | College/University | Doctorate Degree Undergraduate Degree | |
| VIEWRAY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Doctorate Degree Graduate Degree | |
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | President Chief Operating Officer | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Chairman | |
| RUBIUS THERAPEUTICS | Biotechnology | President Chairman | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Founder Corporate Officer/Principal | |
| THIRD HARMONIC BIO, INC. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Viewray Technologies, Inc.
 Viewray Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| CURIS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| ACCELERON PHARMA INC. | Biotechnology | Chairman Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Undergraduate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Verenigd Koninkrijk | 4 |
| Noorwegen | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 10 |
| Commercial Services | 9 |
| Finance | 5 |
Operationeel
| Director/Board Member | 245 |
| Independent Dir/Board Member | 99 |
| Corporate Officer/Principal | 95 |
| Director of Finance/CFO | 41 |
| Undergraduate Degree | 37 |
Sterkste connecties
| Insiders | |
|---|---|
| Mark McDade | 35 |
| Robert Spiegel | 30 |
| Karen Smith | 29 |
| David Epstein | 28 |
| Francois Nader | 28 |
| David Bonita | 27 |
| Mark Chin | 25 |
| Maureen O'Connell | 24 |
| Caley Castelein | 23 |
| Sapna R. Srivastava | 21 |
| Aaron Kantoff | 19 |
| Clay Siegall | 18 |
| Matthias Alder | 18 |
| B. Parshall | 17 |
| Peter Pfreundschuh | 17 |
- Beurs
- Insiders
- Kevin Johnson
- Bedrijfsconnecties